1. PHARMACOKINETIC ANALYSIS AND CLINICAL RESULTS OF THE PHASE 1 DOSE ESCALATION AND EXPANSION CXD101 TRIAL IN RELAPSED, REFRACTORY LYMPHOMA. (June 2017) Authors: Eyre, T.A.; Folkes, L.; Collins, G.; Hildyard, C.; Stratford, M.; Myers, K.; La Thangue, N.; Kerr, D.; Middleton, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗